,,Depression A Cause for Death in Elderly,,
A new study which focused on depression in elderly people living in th...The study involved 250 participants in a community health program. ...Researchers say “After adjusting for various demographic factors 1...One of the strengths of this study is that it involves people living...
(Date:10/10/2008)... , DANVILLE, PA The American Nurses Credentialin...enter (GMC) as a Magnet hospital. The news came vi...rses and staff who broke out with cheers and appla...vania hospitals and only 294 hospitals in the Uni...than 6,000 hospitals are eligible for this recogni...
(Date:10/10/2008)... Study suggests poor self-care partly to blame ,... a group of Medicare beneficiaries who have diabet...eath rate, according to a new study. , Publis...al Internal Medicine , researchers from the Univer...iaries (average age of 75.6 years) who had diabete...
(Date:10/10/2008)... , Honoring excellence in...EHRs), the Healthcare Information and Management S... the 2008 Davies Awards in the Organizational, Amb...es. , Chicago, IL (PRWEB)...plementation of electronic health records (EHRs), ...
(Date:10/10/2008)... NEW YORK, Oct. 10 /PRNewswire/ -- The Johns ... a novel multimedia educational program,"Optimizi...ers to Treatment,Selection," to present recent key...ncer treatment., In recent years, advancements in...herapeutic and biologic treatment combinations tha...
Breaking Medicine News(10 mins):Health News:Geisinger Medical Center earns prestigious Magnet designation 2Health News:Older Diabetics With Depression Face Higher Death Rate 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 2Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 3Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 4Health News:2008 HIMSS Davies Awards: Nation's Outstanding Healthcare Organizations Recognized 5Health News:Latest Research on Breast Cancer Presented in a Virtual E-Conference CME Course 2(Date:10/9/2008)...ire-FirstCall/ -- Diamyd Medical reports,that the ...England Journal,of Medicine, has published an arti...iamyd(R) diabetes vaccine for type 1 diabetes., (...4/297194 ), The article is now available on the ...l be in print on October 30. It presents the,resul...
(Date:10/8/2008)...ers Research That May Offer New Hope to,Heart Fail...ionally, over 3,000 people are,waiting for a heart... half,of those will receive a transplant. Now, pio...is paving the way for how to treat congestive hear... News Release, go to:, http://www.prnewswire.com/m...
(Date:10/8/2008)...y of Poly-ICR as Vaccine Adjuvant, SAN DIEGO, Oct...icals,Corporation (TSX: NVN) today presented posit...etary Toll-like Receptor 3 agonist, Poly IC-Poly,A...2008 in Lyon, France.,Study results demonstrated P...the Toll-like Receptor 3 (TLR3) pathway. Data show...
(Date:10/7/2008)...ire/ -- McLaren Health Care and its Great,Lakes Ca...eading medical,minds to share the latest work unde...al cancer treatments. The October 11th symposium, ...en,s Sukamal Saha, M.D., an,award-winning surgical...r,colorectal cancer has gained worldwide recogniti...
Breaking Medicine Technology:Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 2Video: Answer to Curing a Failing Heart May Exist in Body's Own 'Do-It-Yourself' Repair Kit 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 2Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 3Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 4Nventa Presents Findings on Proprietary Toll-like Receptor 3 (TLR3) Agonist, Poly-ICR, at World Vaccine Congress 5News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments 2AARP Calls for Action on Top Consumer Priorities 21189 1AARP Calls for Action on Top Consumer Priorities 21189 2Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 1Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 2Death on the Net 3F Over 60 25 of Medicines Sold by Online Pharmacies are Fake 21187 3OrthoSynetics 28TM 29 Donates Body Armor to New Orleans Police Department 21185 1OrthoSynetics 28TM 29 Donates Body Armor to New Orleans Police Department 21185 2AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 1AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 2AHCA Alliance Praise New Bipartisan Bi Cameral Effort Urging Bush Administration to Forego Medicare Cuts 21183 3...ire-FirstCall/ -- IDM,Pharma, Inc. today announced... clinical trial and data from the Phase II EP-2101...al trial will be,presented at the 2007 American So...ing in Chicago on June 1-5 2007. , , UVIDEM pre...ogical responses in patients with malignant, ...
...rstCall/ -- Lev,Pharmaceuticals, Inc. ("Lev" or th... patient treatment in the prophylactic portion of,...tor (C1-INH) for,hereditary angioedema (HAE). The ...aluated the efficacy and safety of C1-INH,replacem...rophylactic treatment to prevent HAE attacks. , Le...
Other Medicine Technology:IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 2IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 3IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 4IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 5IDM Pharma Announces UVIDEM(R) and EP-2101 Data Presentations at,2007 ASCO Annual Meeting 6Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 2Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 3Lev Pharmaceuticals Completes Phase III Prophylaxis Trial of,C1-Esterase Inhibitor for Hereditary Angioedema 4...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: